Cyclin dependent kinase inhibitors as a new potential therapeutic option in management of COVID-19.
Título
Cyclin dependent kinase inhibitors as a new potential therapeutic option in management of COVID-19.
Autor
Aboubaker Alzwi, Mohamed Gargouri, Anis Abobaker
Fecha
2021
Identificador
10.1016/j.mehy.2020.110380
Fuente
Medical hypotheses
Archivos
Colección
Citación
Aboubaker Alzwi, Mohamed Gargouri, Anis Abobaker, “Cyclin dependent kinase inhibitors as a new potential therapeutic option in management of COVID-19.,” SOCICT Open, consulta 18 de abril de 2026, https://www.socictopen.socict.org/items/show/8135.
Position: 15131 (20 views)